Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01970332 · ClinicalTrials.gov registry record · NA
Mechanisms That Produce the Leg Dysfunction of Claudication & Treatment Strategies
A NA study of Peripheral Arterial Disease, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 220
- Enrollment target
- 1
- Study location
NCT01970332: Completed NA study of Peripheral Arterial Disease, sponsored by University of Nebraska.
NCT01970332 is a NA study of Peripheral Arterial Disease that has completed, run by University of Nebraska. The registered enrollment target is 220 participants, below the 4,203-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01970332, a NA study of Peripheral Arterial Disease, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
Intermittent claudication afflicts 5% of the US population older than 55 years of age and develops along with hardening of the arteries of the legs. Claudicating patients limp and can only walk very short distances because their legs hurt. This protocol evaluates the mechanisms that may produce the leg dysfunction of claudication and its successful completion can ultimately produce significant new diagnostic and treatment strategies for the care of claudicating patients.
Primary Outcome
Initial Claudication Distance, Absolute Claudication Distance, 6-Minute Walking Distance
Conditions Studied
Interventions
- PROCEDURE Revascularization Surgery
- OTHER Supervised exercise therapy
Study Locations (1)
Nebraska
- Veterans Affairs Medical Center, Omaha - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2010-09-01 |
| Est. Completion | 2016-05-30 |
| Phase | NA |
What the finished NCT01970332 record still lists
NCT01970332 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 4,203-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which Revascularization Surgery is the first listed.
NCT01970332 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT01970332 about?
NCT01970332 is a clinical study titled "Mechanisms That Produce the Leg Dysfunction of Claudication & Treatment Strategies". Intermittent claudication afflicts 5% of the US population older than 55 years of age and develops along with hardening of the arteries of the legs. Claudicating patients limp and can only walk very short distances because their legs hurt. This protocol evaluates the mechanisms that may produce the ...
What is the current status of trial NCT01970332?
This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2010-09-01. Estimated completion is 2016-05-30.
What conditions does trial NCT01970332 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
What interventions are being tested in trial NCT01970332?
The interventions under investigation include: Revascularization Surgery (PROCEDURE), Supervised exercise therapy (OTHER).
Who is sponsoring clinical trial NCT01970332?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01970332 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01970332's enrollment target sits among peer trials
220 21st of 79 higher than 59 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI